MDSpire - MDSpire Home
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

MDSpire News

  • September 3, 2026
AI cuts lesion measurement time by 34%
  • Andrea Surnit
  • September 3, 2026
  • 4 min

Objective: To evaluate the impact of artificial intelligence (AI) assistance on lesion measurement time and classification agreement in follow-up CT examination

...more

MDSpire News

  • September 3, 2026
Estriol may ease menopause-related cognitive decline
  • Andrea Surnit
  • September 3, 2026
  • 3 min

Objective: To assess the effects of estriol-based hormone treatment on cognitive symptoms in menopausal women. Approach: Study Design: A case series involving 2

...more
2 min

Baptist Health South Florida

  • September 3, 2026
Fellowship-Trained Neuro-Oncologist Nishika Karbhari, M.D., Joins Baptist Health Herbert Wertheim Cancer Institute
  • September 3, 2026
  • 2 min

Objective: To announce the joining of Dr. Nishika Karbhari, a neuro-oncologist, to Baptist Health Herbert Wertheim Cancer Institute. Approach: Professional Back

...more

Baptist Health South Florida

  • September 3, 2026
Spencer Streit, D.O., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist and Hematologist
  • September 3, 2026
  • 2 min
  1. Spencer Streit, D.O., has joined the Eugene M. and Christine E. Lynn Cancer Institute as a medical oncologist and hematologist.
  2. Dr. Streit specializes in treating solid tumors, with a particular focus on gastrointestinal cancers.
  3. He completed a hematology-oncology fellowship at Memorial Healthcare System, serving as chief fellow.
  4. Dr. Streit has published research on various cancer topics and is a member of multiple professional organizations.
  5. He emphasizes compassionate, patient-centered care and aims to support patients and their families throughout treatment.
...more

Baptist Health South Florida

  • September 3, 2026
Kriti Ahuja, M.D., Joins Baptist Health Wertheim Cancer Institute as a Breast Medical Oncologist
  • September 3, 2026
  • 2 min
  1. Kriti Ahuja, M.D., joins Baptist Health Wertheim Cancer Institute as a board-certified medical oncologist specializing in breast cancer.
  2. Dr. Ahuja's clinical interests include comprehensive treatment for breast malignancies and research on cancer survivorship and novel therapies.
  3. She earned her medical degree from Maulana Azad Medical College and completed her residency at John H. Stroger, Jr. Hospital.
  4. Dr. Ahuja completed her fellowship in hematology and medical oncology at Roswell Park Comprehensive Cancer Center.
  5. She is fluent in English and Hindi and will provide patient-centered care at Baptist Health Wertheim Cancer Institute.
...more

MDSpire News

  • September 3, 2026
Google clinical leader on health care’s AI ‘epistemic shift’
  • Julia Cipriano, MS, CMPP
  • September 3, 2026
  • 7 min
  1. Dr. Pete Clardy describes health care's transition as an 'epistemic shift' driven by advancements in artificial intelligence.
  2. AI is evolving from early expert systems to complex models that assist clinicians in processing vast amounts of health information.
  3. Successful AI implementation in health care relies on clear problem definition, stakeholder alignment, and effective change management.
  4. Research shows AI can enhance patient interactions, improving trust and generating clinical documentation comparable to human performance.
  5. The rise of AI tools is reshaping the clinician-patient relationship, allowing patients to engage more actively with their health information.
...more

MDSpire News

  • September 3, 2026
AI poised to reshape care
  • Doug Brunk
  • September 3, 2026
  • 7 min
  1. AI may enhance patient care by managing routine tasks, allowing physicians to focus on complex decisions and patient relationships.
  2. Panelists discussed AI's potential to support patients throughout their healthcare journey, raising questions about regulation and responsibility.
  3. AI is well-suited for low-risk tasks, which could improve efficiency and reduce costs in routine care, especially for uninsured patients.
  4. Despite AI advancements, panelists emphasized the enduring need for physicians to provide empathy and handle complex cases.
  5. Regulatory frameworks must evolve to address the challenges posed by AI in healthcare, particularly regarding safety and effectiveness.
...more

The Pathologist

  • September 3, 2026
Proteomics Gives Us the Cancer Traffic Report
  • Kayla Sparks
  • Emanuel "Chip" Petricoin
  • September 3, 2026
  • 12 min
  1. Genomics reveals a tumor's potential through DNA alterations, while functional proteomics shows its actual biological activities.
  2. Functional proteomics bridges the gap between genetic information and tumor behavior, impacting drug response and resistance.
  3. Phosphorylation plays a crucial role in regulating protein activity, which is often undetectable through standard genomic analysis.
  4. Understanding both genomic and proteomic data is essential for accurate therapy selection and predicting treatment outcomes.
  5. Proteomics provides insights into protein activation states and signaling networks, enhancing the understanding of cancer biology.
...more

The Pathologist

  • September 3, 2026
India’s TB Labs Face a Capacity Gap
  • September 3, 2026
  • 3 min

Objective: To assess India's preparedness toward the eradication of tuberculosis (TB) by evaluating the distribution of TB treatment units and diagnostic labora

...more
2 min

The Ophthalmologist

  • September 3, 2026
The Biggest Risk to Your Practice Isn't Competition
  • Rod Solar
  • September 3, 2026
  • 7 min
  1. Dependence on a single surgeon, referral source, or marketing channel poses a greater risk to ophthalmology practices than competition.
  2. Competition anxiety distracts practice owners from addressing internal issues that can lead to stagnation and fragility.
  3. Resilient practices focus on building systems and processes that do not rely on individual performance or memory.
  4. A strong brand identity and positive patient experience are crucial for retaining patients and generating referrals.
  5. Diversifying patient acquisition channels helps practices mitigate risks associated with reliance on a single source.
...more

The Ophthalmologist

  • September 3, 2026
Endophthalmitis: A Case for Acting Early
  • September 3, 2026
  • 3 min

Objective: To assess the feasibility and potential benefits of early surgical intervention (vitrectomy) in patients with endophthalmitis following intraocular p

...more

Baptist Health South Florida

  • September 3, 2026
Florida’s First Pediatric Cardiac Robotic Surgery Performed at Nicklaus Children’s Hospital
  • September 3, 2026
  • 5 min
  1. Nicklaus Children's Hospital and Baptist Health performed Florida's first robotics-assisted atrial septal defect repair in a pediatric patient.
  2. The procedure utilized a robotic-assisted surgical system for precise movements through small incisions, enhancing recovery and cosmetic outcomes.
  3. Collaboration among pediatric and adult cardiac specialists was crucial for adapting robotic techniques to pediatric cardiac care.
  4. This milestone reflects a partnership that combines expertise from Nicklaus Children's Hospital, Baptist Health, and Florida International University.
  5. Robotic technology in pediatric cardiac surgery is limited to a few specialized centers, making this achievement significant in the field.
...more

The Medicine Maker

  • September 3, 2026
What Will Drug Development Look Like in 2036?
  • September 3, 2026
  • 12 min
  1. The distinction between small molecules and biologics will diminish, with new technologies targeting previously inaccessible disease mechanisms.
  2. AI will transform drug development by enhancing efficiency in target identification, clinical trial design, and patient recruitment.
  3. Drug development will become more integrated and data-driven, utilizing real-time learning systems and digital twins for predictive design.
  4. The majority of early-stage drug development is expected to shift to Asia due to more efficient operational models.
  5. Regulatory review times are anticipated to decrease by 30%, improving the prediction of drug efficacy using real-world evidence.
...more

The Ophthalmologist

  • September 3, 2026
Rising Stars of Retina
  • September 3, 2026
  • 1 min

Objective: To celebrate 10 ophthalmologists who are significantly impacting the future of the retina specialty. Approach: Selection Process: Honorees were selec

...more
1 min

The Analytical Scientist

  • September 3, 2026
Can Tumor Organoids Make Drug Discovery More Predictive?
  • September 3, 2026
  • 8 min
  1. Patient-derived tumor organoids (PDTOs) replicate key features of individual cancers, offering a superior model for drug screening compared to traditional 2D cultures.
  2. PDTOs capture tumor heterogeneity, enabling the reconstruction of diverse cancer pathways and unique disease states for personalized treatment approaches.
  3. Chemotherapy-sensitive profiling with PDTOs is currently the only method for empirically-based patient stratification in pancreatic cancer.
  4. Dual- and multi-agent profiling in PDTOs shows higher accuracy in predicting drug efficacy compared to monotherapy testing.
  5. Integrating tissue microenvironment components into PDTOs could enhance drug discovery by providing a more comprehensive representation of tumors.
...more

Frontiers In Oncology

  • September 3, 2026
Brain Metastasis from Primary Vaginal Clear Cell Adenocarcinoma Unrelated to Diethylstilbestrol: A Case Study and Literature Review
  • Esther Anyimadu Buckson
  • Obi Emereole
  • John Richard Ouma
  • September 3, 2026
  1. Primary clear cell adenocarcinoma of the vagina (PCCAV) accounts for 5%-10% of primary vaginal cancers and is linked to poorer prognosis when non-DES-related.
  2. A 17-year-old female presented with cerebral metastases from non-DES-related PCCAV, experiencing left-sided weakness and seizures.
  3. CT imaging revealed a right parietal mass and pulmonary metastases, confirming the diagnosis of metastatic clear cell vaginal adenocarcinoma.
  4. The patient underwent emergent gross total excision of the brain lesion, but her prognosis remained poor, leading to palliative care.
  5. This case highlights the lack of established management guidelines for metastatic PCCAV and the need for further research in this area.
...more

Frontiers In Oncology

  • September 3, 2026
A Case Study of Composite Pheochromocytoma Developing 13 Years Post-Adrenalectomy for Primary Pheochromocytoma
  • Min Min
  • Jie Zhang
  • Gui-xi Liu
  • Jing He
  • September 3, 2026
  1. A 61-year-old man developed composite pheochromocytoma 13 years after resection of a primary pheochromocytoma.
  2. Imaging revealed a 2.6 cm nodule in the left adrenal region, raising suspicion for recurrent pheochromocytoma.
  3. Surgical intervention involved partial left adrenalectomy, revealing multiple solid masses and confirming composite pheochromocytoma.
  4. Histopathological analysis showed cystic changes and invasion of adipose tissue in the composite pheochromocytoma.
  5. Long-term surveillance is essential due to the potential for local recurrence and development of new adrenal tumors.
...more

Frontiers In Cardiovascular Medicine

  • September 3, 2026
Evaluation of Carotid Intima-Media Thickness and Epicardial Fat Thickness for Cardiovascular Risk Assessment in Asymptomatic Adults from South India
  • Ramesh Sankaran
  • Dolly Agarwal
  • Rahul Mittal
  • Shankar Srinivasan
  • Nagendra Boopathy Senguttuvan
  • Alex Karev
  • Sadhanandham Shanmugasundaram
  • Balasubramaniyan Jayanthi Venkata
  • Vinod Kumar Balakrishnan
  • Preetam Krishnamurthy
  • Sadagopan Thanikachalam
  • Murthy Jayanthi Satyanarayana
  • September 3, 2026
  1. The study evaluated carotid intima-media thickness (cIMT) and epicardial fat thickness (EFT) as non-invasive markers of cardiovascular risk in asymptomatic adults.
  2. Participants with cardiovascular risk factors had significantly higher cIMT and EFT compared to controls, indicating a correlation with cardiovascular risk.
  3. The prevalence of abnormal cIMT increased significantly with age, highlighting the importance of age in cardiovascular risk assessment.
  4. Hypertension, diabetes mellitus, and dyslipidaemia were significantly associated with increased cIMT and EFT values in the study population.
  5. The findings support the use of cIMT and EFT as complementary imaging markers to enhance cardiovascular risk stratification in asymptomatic adults.
...more